New predictive protocol for therapeutic treatment of renal and nonrenal anemias with recombinant human erythropoietin with a simple immunoenzymatic dosage of serum burst-promoting activity (IL-3, IL-4, GM-CSF)

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples